We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

143 hedge funds and large institutions have $699M invested in iTeos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 34 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 34

1.36% less ownership

Funds ownership: 104.5% → 103.14% (-1.4%)

6% less funds holding

Funds holding: 152 → 143 (-9)

9% less capital invested

Capital invested by funds: $768M → $699M (-$69M)

32% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 28

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
143
Holders Change
-9
Holders Change %
-5.92%
% of All Funds
2.46%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
63
Reduced
34
Closed
28
Calls
$201K
Puts
–
Net Calls
+$201K
Net Calls Change
-$3.97M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$14M
2
BlackRock
BlackRock
New York
+$13.7M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$10.7M
4
Millennium Management
Millennium Management
New York
+$9.53M
5
Ameriprise
Ameriprise
Minnesota
+$4.69M

Top Sellers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
-$16.9M
2
Deutsche Bank
Deutsche Bank
Germany
-$13.4M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$12.9M
4
State Street
State Street
Massachusetts
-$8.53M
5
EC
EcoR1 Capital
California
-$5.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
101
American International Group
New York
$247K +$10.5K +456 +4%
MIM
102
MetLife Investment Management
New Jersey
$242K – – –
ZCM
103
Zebra Capital Management
Connecticut
$234K +$283K +12,271 New
LSERS
104
Louisiana State Employees Retirement System
Louisiana
$223K +$43.8K +1,900 +19%
DekaBank Deutsche Girozentrale
105
DekaBank Deutsche Girozentrale
Germany
$215K – – –
Mirae Asset Global Investments
106
Mirae Asset Global Investments
South Korea
$212K +$256K +11,124 New
AB
107
Amalgamated Bank
New York
$209K +$30K +1,304 +14%
TRCT
108
Tower Research Capital (TRC)
New York
$199K +$113K +4,919 +89%
OPERF
109
Oregon Public Employees Retirement Fund
Oregon
$155K +$34.6K +1,500 +23%
Lazard Asset Management
110
Lazard Asset Management
New York
$117K -$16.4K -710 -10%
TRSOTSOK
111
Teachers Retirement System of the State of Kentucky
Kentucky
$117K +$142K +6,143 New
VEA
112
Virtus ETF Advisers
New York
$111K +$875 +38 +0.7%
MOACM
113
Mutual of America Capital Management
New York
$93K +$34.1K +1,481 +44%
QT
114
Quantbot Technologies
New York
$83K +$23.6K +1,026 +30%
SOW
115
State of Wyoming
Wyoming
$83K +$84.2K +3,656 +508%
Robeco Institutional Asset Management
116
Robeco Institutional Asset Management
Netherlands
$57K – – –
Ensign Peak Advisors
117
Ensign Peak Advisors
Utah
$43K – – –
Wells Fargo
118
Wells Fargo
California
$42K -$5.09K -221 -9%
Zurich Cantonal Bank
119
Zurich Cantonal Bank
Switzerland
$40K – – –
PNC Financial Services Group
120
PNC Financial Services Group
Pennsylvania
$37K +$8.25K +358 +22%
Amundi
121
Amundi
France
$35K +$41.4K +1,799 New
KBC Group
122
KBC Group
Belgium
$34K – – –
GCM
123
Gladius Capital Management
Illinois
$31K +$36.5K +1,586 New
AIP
124
Ameritas Investment Partners
Nebraska
$30K – – –
MLICM
125
Metropolitan Life Insurance Company (MetLife)
New York
$26K – – –
3 4
5
6 7

ITOS Hedge Fund Activity: Q3 2022 in Review

143 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q3 2022, worth a combined $699M — down 9% from $768M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ITOS and 19 opened new positions — a net loss of 9 holders — while 34 trimmed existing stakes and 63 added.

The largest buyer was Citadel Advisors, adding an estimated $14M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $16.9M sold.

  • 143 institutional investors held iTeos Therapeutics (ITOS) as of Q3 2022, down from 152 in Q2 2022.
  • Funds reported $699M of iTeos Therapeutics stock for Q3 2022, down 9% quarter-over-quarter.
  • 19 funds opened new iTeos Therapeutics positions in Q3 2022 and 28 closed out, a net change of -9 holders.
  • The largest iTeos Therapeutics buyer in Q3 2022 was Citadel Advisors, an estimated $14M added.
  • The largest iTeos Therapeutics seller in Q3 2022 was Rubric Capital Management (New York), an estimated $16.9M sold.

Based on aggregated 13F filings for Q3 2022.